which roche stock

Is Roche stock a good long-term buy?

The stock isn't a good bet for traders who want to profit from the stock's day-to-day volatility. Roche (RHHBY) stock is a good long-term buy. Roche is a high-quality stock with an attractive valuation. Long-term investors can buy at this price for long-term stable returns.

Is the Roche Group a US company?

US investors The Roche Group (of which Genentech is a wholly-owned member) is traded in the United States as a U.S.-dollar denominated American Depositary Receipt (“ADR”) on the OTCQX International Premier market under the stock symbol: RHHBY. ADRs are U.S. dollar-denominated securities which represent ownership of equity in non-U.S. companies.

What are analysts'1 year price targets for Roche's stock?

11 equities research analysts have issued 1 year price objectives for Roche's stock. Their forecasts range from $46.42 to $46.42. On average, they expect Roche's share price to reach $46.42 in the next twelve months. This suggests that the stock has a possible downside of 9.2%.

What does a hold rating on Roche's stock mean?

A hold rating indicates that analysts believe investors should maintain any existing positions they have in RHHBY, but not buy additional shares or sell existing shares. View analyst ratings for Roche or view top-rated stocks. How has Roche's stock price been impacted by Coronavirus?

Is Roche Holding a good stock to buy?

Roche Holding AG (RHHBY) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices.

What is the Stock symbol for Roche?

RHHBYThe Roche ADR (stock symbol: RHHBY) allows U.S. investors to buy or trade locally in Roche Group shares, which are otherwise listed on the SIX Swiss Exchange.

Where is Roche listed?

SIX Swiss ExchangeRoche's non-voting equity securities and Roche bearer shares are listed on SIX Swiss Exchange.

Is Roche Diagnostics publicly traded?

F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel.

How do I invest in Roche?

How can I invest in Roche? For an investor in the United States, a position in Roche can be acquired through an American Depositary Receipt (ADR) traded on OTCQX International Premier under the symbol RHHBY.

How do I buy RHHBY stock?

Shares of RHHBY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

Does Roche have dividends?

When does Roche pay dividends? Roche pays a dividend 1 times a year. The payment month is March. The dividend calendar shows you for more than 1,000 dividend stocks in which month which company distributes its dividends.

Why is Roche stock going up?

Roche's revenue grew 13% y-o-y to $72.4 billion in 2021, aided by Covid-19 diagnostics tests and Ronapreve - a treatment for Covid-19, developed by Regeneron and distributed by Roche outside the U.S. The Covid-19 related products alone accounted for $7 billion of the $72 billion in sales for Roche in 2021.

Is Roche a Fortune 500 company?

See which other companies top our list. Exxon Mobil leads our list of top earners this year....Company Matches.Rank6CompanyRoche Group500 rank188Revenues ($ millions)34,702.811 more columns

Who owns Roche drug company?

Roche is the third-largest pharma company worldwide. Descendants of the founding Hoffmann and Oeri families own slightly over half of the bearer shares with voting rights (a pool of family shareholders 45%, and Maja Oeri a further 5% apart), with Swiss pharma firm Novartis owning a further third of its shares.

Does Roche own Novartis?

Novartis has been a shareholder of Roche since May, 2001 and currently holds 53.3 million bearer shares of Roche's common stock, representing approximately 33% of aggregate outstanding bearer shares.

When did Roche go public?

F. Hoffmann-La Roche & Co. is founded in Basel, Switzerland. 1919: The company goes public.

Why is Roche stock going up?

Roche's revenue grew 13% y-o-y to $72.4 billion in 2021, aided by Covid-19 diagnostics tests and Ronapreve - a treatment for Covid-19, developed by Regeneron and distributed by Roche outside the U.S. The Covid-19 related products alone accounted for $7 billion of the $72 billion in sales for Roche in 2021.

What is Roche market cap?

330.2BPerformance OutlookMarket Cap330.2BPE Ratio (TTM)20.10EPS (TTM)2.07Earnings DateN/AForward Dividend & Yield1.24 (2.99%)3 more rows

What is Roche talking about?

What did Novartis want from Roche?

Roche Holding AG (OTC: RHHBY) is reportedly talking to the FDA about its Alzheimer’s disease drug candidate, gantenerumab. CEO Severin Schwan declined to speculate on the outcome of the talks, Reuters reported.

What is the ticker symbol for Roche?

Novartis AG wants Roche Holding AG to return $210 million after accusing its Swiss rival of inappropriately pocketing fees from a 16-year-old patent licensing agreement, according to a lawsuit in U.S. District Court. The dispute, launched by Novartis in a California state court but recently shifted to a federal court, stems from a 2005 deal requiring U.S.-based Chiron Corp to make payments to Roche's U.S. Genentech unit for use of its intellectual property.

What is Roche stock worth in 2020?

Roche trades on the OTCMKTS under the ticker symbol "RHHBY."

What is Roche Holding AG?

Roche's stock was trading at $40.91 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, RHHBY shares have increased by 14.3% and is now trading at $46.76. View which stocks have been most impacted by COVID-19.

What is the PEG ratio of Roche?

Roche Holding AG engages in the prescription pharmaceuticals and diagnostics businesses in Switzerland, Germany, and internationally. It offers pharmaceutical products for treating anemia, cancer, cardiovascular, central nervous system, dermatology, hepatitis B and C, HIV/AIDS, inflammatory and autoimmune, intensive care medicine, leukemia, lymphoma, metabolic disorders, ophthalmology, respiratory disorders, rheumatoid arthritis, skin cancer, and transplantation. The company also offers in vitro diagnostics solutions for indications, such as cardiology, hematology, blood donor screening, coagulation, infectious disease, gynecology, oncology, and women's health. In addition, it supplies diagnostic instruments, reagents, consumables, and test kits for use in the diverse research market. Roche Holding AG has collaboration with Gilead Sciences, Inc. for COVID-19; a license and collaboration agreement with Shionogi & Co., Ltd. to develop and commercialize Xofluza, as well as SemaThera Inc. to develop biologicals for the treatment of diabetic retinopathy and other ischemic retinal diseases; and has collaboration with Affimed N.V to study AFM24 in combination with PD-L1 checkpoint inhibitor in EGFR expressing solid tumors. The company was founded in 1896 and is headquartered in Basel, Switzerland.

Does Roche have a long track record of dividend growth?

Roche has a PEG Ratio of 2.46. PEG Ratios above 1 indicate that a company could be overvalued.

What companies did Roche acquire?

Roche does not have a long track record of dividend growth.

What is ZER research?

In September 2014, Roche acquired InterMune for $8.3 billion and added Esbriet to its portfolio. During the first quarter of 2018, Roche acquired Flatiron Health and Ignyta, Inc. While Flatiron Health will enable accelerate development and delivery of breakthrough medicines for oncology patients, Ignyta’s lead molecule entrectinib targets tumors with one of two genetically defined gene rearrangements: ROS1 fusions in NSCLC, and NTRK fusions across a broad range of solid tumors. In July 2018, Roche acquired Foundation Medicine Inc. to broaden its healthcare portfolio, and aims to further advance molecular insights and the broad availability of high-quality comprehensive genomic profiling, both key enablers for the development of new cancer treatments and optimal patient care. Roche’s subsidiary, Genentech also obtained full rights to Jecure’s entire preclinical portfolio of NLRP3 inhibitors. In December 2019, Roche acquired Spark Therapeutics, Inc.

How many X is Zacks?

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

How many sectors are there in Zacks?

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

What are the different grades for stocks?

The Zacks Sector Rank assigns a rating to each of the 16 Sectors based on their average Zacks Rank.

Does Zackstrade endorse or recommend investment strategies?

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

What is Roche pharmaceutical?

The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities.

Is Roche a good stock to buy?

Roche is a Swiss pharmaceutical giant that's engaged in prescription pharmaceuticals and diagnostics businesses.

Is Roche stock rising?

Roche is a high-quality stock with an attractive valuation. Long-term investors can buy at this price for long-term stable returns. Also, COVID-19 testing remains a tailwind for the stock in 2021. The recent market rotation from growth to value stocks in light of rising interest rate expectations and inflation should benefit quality value plays like Roche.